Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture vs Dry Needling vs Botox for MPDS
NCT06013644Phase 1Unknown
- Sponsor
- Cairo University
- Start
- Jun 2023
- Primary completion
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of botulinum toxin type A in myofascial pain syndrome (MPS) (3 arms), sponsored by Cairo University. Primary endpoint: Change of electrical activity of mastication muscles at 6 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
myofascial pain syndrome (MPS)
Beyond the preview
Go deeper on NCT06013644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06013644.